Medical cannabis producer partnership in growth strategy

Added on 20 October 2023

Tags

Medical cannabis producer partnership in growth strategy

Leicestershire-based Medical cannabis producer Dalgety has announced a new contract agreement with Grow Pharma and its licensed partner JV Partner IPS Pharma.

This partnership will enable the commercial supply of pharmaceutical-grade THC-rich prescription medicines to the UK market.

Grow Parma offers education for healthcare professionals as well as one-to-one advice, learning events and prescription support for new doctors.

James Leavesley, chief operating officer at Dalgety, said: “We began discussions with Grow more than two years ago and we share its ambition as a leader within the medical cannabis industry. From cultivation and processing, through to patient experience, we’re aligned in our aim of providing the highest quality medicine and service to patients. I’m excited to announce that this agreement has now come to fruition.”